Samsung Biologics receives EcoVadis Platinum, the highest sustainability rating

Core Insights - Samsung Biologics has achieved the EcoVadis Platinum Sustainability Rating, the highest recognition for corporate sustainability performance, placing it in the top one percent of evaluated companies globally [1][2][10] Sustainability Performance - The EcoVadis rating evaluates corporate social responsibility across four areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement [2] - Samsung Biologics was previously awarded the Gold Sustainability Rating in 2024, indicating a consistent improvement in sustainability practices [3] Management Commitment - John Rim, President and CEO, emphasized the company's commitment to responsible business practices and long-term partnerships that contribute to a sustainable healthcare ecosystem [4] - The company has enhanced sustainability initiatives, including increased use of renewable energy and improved ethical compliance frameworks [4] Industry Engagement - Samsung Biologics received an 'A' rating in Water Security from the Carbon Disclosure Project (CDP) in December 2025 [4] - As a Champion of the Sustainable Markets Initiative Health Systems Task Force, the company engages global suppliers in decarbonization efforts [4] Manufacturing Capacity - Samsung Biologics has a combined biomanufacturing capacity of 785,000 liters, with an additional 60,000 liters expected from a facility acquisition in Rockville, Maryland, by the end of Q1 2026 [7] - The company utilizes advanced technologies for various biopharmaceutical modalities, including multispecific antibodies and mRNA therapeutics [7] Operational Excellence - The ExellenSâ"¢ framework is implemented across the manufacturing network to ensure standardized designs and processes, enhancing manufacturing continuity [8] - The global manufacturing network includes operations in Korea, the U.S., and Japan, with a focus on delivering high-quality biomedicines [9]